Koers ZoomMed Inc. Other OTC
Aandelen
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 11,15K 8,19K 7,54K | Omzet 2023 | 13,01K 9,55K 8,8K | Marktkapitalisatie | 2,03 mln. 1,49 mln. 1,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -734K -676K | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | 168 x |
Nettoliquiditeiten 2022 | 161K 118K 109K | Nettoschuld 2023 | 393K 288K 266K | EV/omzet 2023 | 186 x |
K/w-verhouding 2022 |
-1,66
x | K/w-verhouding 2023 |
11,6
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 93,02% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yves Marmet
CEO | Chief Executive Officer | - | 01-10-05 |
Director of Finance/CFO | - | 01-10-05 | |
Sébastie Ouellet
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-05 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Powell
BRD | Director/Board Member | - | 01-02-05 |
André Marmet
PRN | Corporate Officer/Principal | - | 01-10-05 |
Director of Finance/CFO | - | 01-10-05 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,22% | 33,98 mld. | |
+21,99% | 8,16 mld. | |
+31,37% | 4,26 mld. | |
-30,15% | 2,65 mld. | |
-19,11% | 1,4 mld. | |
-28,03% | 1,27 mld. | |
-33,21% | 1,16 mld. | |
+13,85% | 1,02 mld. | |
-34,50% | 917 mln. |